Drug · DIN 02469596
KANUMA
20 MG/10 ML SINGLE-USE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 5, 2018; first marketed April 5, 2018.
- Drug Identification Number (DIN)
- 02469596
- Company (DIN owner)
- Alexion Pharma GmbhBaar, --, Switzerland
- Schedule
- Prescription; Schedule d
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Sebelipase alfa A16AB14
- Class
- Human
- Record last updated
- August 12, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SEBELIPASE ALFA | 2 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 15, 2017: NOC 20164New Drug Submission (NDS)